The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease

Human Brain Mapping

Volumn 35, Issue 5, 2014, Pages 2206-2219

  Shine, James M ^a   Halliday, Glenda M ^b,c   Gilat, Moran ^a   Matar, Elie ^a   Bolitho, Samuel J ^a   Carlos, Maria ^a   Naismith, Sharon L ^a   Lewis, Simon J G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bistable percept paradigm; Functional magnetic resonance imaging; Hallucinations; Parkinson's disease; Visual misperceptions

Indexed keywords

DOPAMINE;

ADULT; ANTERIOR INSULA; ARTICLE; BISTABLE PERCEPT PARADIGM; BOLD SIGNAL; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DEFAULT MODE NETWORK; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DORSAL ATTENTION NETWORK; FRONTAL EYE FIELD; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; NERVE CELL NETWORK; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; VENTRAL ATTENTION NETWORK; VISUAL ACUITY; VISUAL DISORDER; VISUAL HALLUCINATION; VISUAL MISPERCEPTION; VOXEL BASED MORPHOMETRY; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN MAPPING; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTUAL DISORDERS; PHOTOSTIMULATION;

AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PERCEPTUAL DISORDERS; PHOTIC STIMULATION;

EID: 84898024837     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22321     Document Type: Article

References (61)

1. Ashburner J, Friston KJ (2000): Voxel-based morphometry-The methods. NeuroImage 11:805-821.
2. Asplund CL, Todd JJ, Snyder AP, Marois R (2010): A central role for the lateral prefrontal cortex in goal-directed and stimulus-driven attention. Nat Neurosci 13:507-512.
3. Beck AT, Steer RA, Brown GK (1996): Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
4. Berrios G (1982): Tactile hallucinations: conceptual and historical aspects. J Neurol Neurosurg Psychiatry 45:285-293
5. Binder JR, Frost JA, Hammeke TA, Bellgowan PS, Rao SM, Cox RW (1999): Conceptual processing during the conscious resting state: A functional MRI study. J Cognit Neurosci 11:80-93.
6. Brett M, Anton J, Valabregue R, Poline J (2002): Region of interest analysis using an SPM toolbox [abstract]. Presented at the 8th International Conference on Functional Mapping of the Human Brain. Neuroimage 16(2).
7. Bronnick K, Aarsland D, Larsen JP (2005): Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand 112:201-207.
8. Collerton D, Perry E, McKieth I (2005): When people see things that are not there: A novel perception and attention deficit model of recurrent complex visual hallucinations. Behav Brain Sci 28:737-757.
9. Corbetta M, Shulman GL (2002): Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201-215.
10. Corrigan J, Hinkeldey MS (1987): Relationships between parts A and B of the Trail Making Test. J Clin Psychol 43:402-409.
11. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V (1998): Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 21:289-295.
12. Diederich NJ, Goetz CG, Stebbins GT (2005): Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model. Mov Disord 20:130-140.
13. Diederich NJ, Fenelon G, Stebbins G, Goetz CG (2009): Hallucinations in Parkinson disease. Nat Rev Neurol 5:331-342.
14. Elliot DB, Sanderson K, Conkey A (1990): The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Physiol Opt 10:21-24.
15. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. (2007): Clinical diagnostic criteria for dementia associated with parkinson's disease. Mov Disord 22:1689-1707.
16. Fenelon G, Mahieux F, Huon R, Ziegler M (2000): Hallucinations in parkinson's disease: Prevalence, phenomenology and risk factors. Brain 124:733-745.
17. Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G. (2010): A 12-year population-based study of psychosis in parkinson disease. Arch Neurol 67:996-1001.
18. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME (2005): The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 102:9673-9678.
19. Fox MD, Corbetta M, Snyder AZ, Vincent JL, Raichle ME (2006): Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems. Proc Natl Acad Sci USA 103:10046-10051.
20. Gagnon JF, Postuma RB, Joncas S, Desjardins C, Latreille V (2010): The montreal cognitive assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder. Mov Disord 2010;25:936-940.
21. Gallagher DA, Parkkinen L, O'Sullivan SS, Sprat A, Shah A, Davey CC, Bremner FD, Revesz T, Williams DR, Lees AJ, Schrag A. (2011): Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 134:3299-3309.
22. Goetz CG, Tanner C, Klawans H (1982): Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 139:494-497.
23. Goetz CG, Vogel C, Tanner CM, Stebbins GT (1998): Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 51:811-814.
24. Goetz C, Fan W, Leurgans S, Bernard B, Stebbins G (2006): The malignant course 'benign hallucinations' in Parkinson's disease. Arch Neurol 2006;63:713-716.
25. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, and LaPelle N (2007): Movement Disorder Society-Sponsored Revision of the Unifited Parkinson's Disease Rating Scale (MDS-UPDRS): Process, Format, and Clinimetric Testing Plan. Mov Disord 22:41-47.
26. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002): Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125 (Part 11):2431-2445.
27. Honey CJ, Sporns O, Cammoun L, Gigandet X, Thiran JP, Meuli R, Hagmann P. (2009): Predicting human resting-state functional connectivity from structural connectivity. Proc Natl Acad Sci USA 106:2035-2040.
28. Horwitz B, Warner B, Fitzer J, Tagamets MA, Husain FT, Long TW (2005): Investigating the neural basis for funcational and effective connectivity. Application to fMRI. Philos Trans R Soc Lond B Biol Sci 360:1093-1108.
29. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, et al. (2010): Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81:650-657.
30. Ibarretxe-Bilbao N, Junque C, Marti MJ, Tolosa E (2011): Cerebral basis of visual hallucinations in Parkinson's disease: Structural and functional MRI studies. Neurol Sci 310:79-81.
31. Janzen J, van't Ent D, Lemstra AW, Berendse HW, Barkhof F, Foncke EMJ (2012): The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: Preliminary results of a voxel-based morphometry study. J Neurol 259:147-154.
32. Lee HJ, Youn JM, Mary JO, Gallagher M, Holland PC (2006): Role of substantia nigra-amygdala connections in surprise-induced enhancement of attention. J Neurosci 26:6077-6081.
33. Lewis SJG, Shine JM, Duffy S, Halliday GM, Naismith SL (2012): Anterior cingulate integrity: Executive and neuropsychiatric features in parkinson's disease. Mov Disord 27:1262-1267.
34. Llebaria Gm Pagonabarraga J, Martinez-Corral M, Garcia-Sanchez C, Pascual-Sedano B, Gironell A, Kulisevsky J (2010): Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Mov Disord 25:2785-2791.
35. Lu J, Sherman D, Devor M, Saper CB (2006): A putative flip-flop switch for control of REM sleep. Nature 441:589-594.
36. Mazaika PK, Whitfield S, Cooper JC (2005): Detection and repair of transient artifacts in fMRI data. NeuroImage 26:S36.
37. Manni R, Terzaghi M, Ratti PL, Repetto A, Zangaglia R, Pacchettim C (2011): Hallucinations and REM sleep behavior disorder in Parkinson's disease: Dream imagery intrusions and other hypotheses. Conscious Cogn 20:1021-1026.
38. Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serranoduenas M, Carod Artal FJ, Rojo Abuin JM, Aarsland D. (2011): Dementia associated with Parkinson's disease: Applying the movement disorder society task force criteria. Parkinsonism Relat Disord 17:621-624.
39. Mazoyer B, Zago L, Mellet E, Bricogne S, Etard O, Houdé O, Crivelo F, Joliot M, Petit L, Tzourio-Mazoyer N. (2001): Cortical networks for working memory and executive functions sustain the conscious resting state in man. Brain Res Bull 54:287-298.
40. Menon V, Uddin LQ (2010): Saliency, switching, attention and control: A network model of insula function. Brain Struct Funct 214:655-667.
41. Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T (2009): Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 132:2980-2993.
42. Naismith SL, Shine JM, Lewis SJG (2010): The specific contributions of set-shifting to freezing of gait in Parkinson's disease. Mov Disord 25:1000-1004.
43. Nomura T, Inoue Y, Mitani H, Kawahara R, Miyake M, Nakashima K (2003): Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Mov Disord 18:812-817.
44. Pieri V, Diederich NJ, Raman R, Goetz CG (2000): Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci 172:7-11.
45. Price MJ, Feldman RG, Adelberg D, Kayne H (1992): Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 42:887.
46. Ramírez-Ruiz B, Martí MJ, Tolosa E, Gimenez M, Bargallo N, Vakkdeiruika F, Junque C. (2007): Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 14:750-756.
47. Sanchez-Ramos JR, Ortoll R, Paulson GW (1996): Visual hallucinations associated with parkinson disease. Arch Neurol 53:1265-1268.
48. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C. (2010): Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. Mov Disord 25:615-622.
49. Scaglione C, Vignatelli L, Piazzi G, Marchese R, Negrotti A, Rizzo G, Lopane G, Bassein L, Maestri M, Bernardini S, Martinelli P, Abbruzzese G, Calzetti S, Bonuccelli U, Provini F, Coccagna G; Bologna, Genova, Parma and Pisa Universities group for the study of REM Sleep Behavior Disorder in Parkinson's Disease. (2005): REM sleep behavior disorder in Parkinson's disease: A questionnaire-based study. Neurol Sci 25:316-321.
50. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Grecius MD. (2007): Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27:2349-2356.
51. Shine JM, Halliday GM, Naismith SL, Lewis SJG (2011): Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? Mov Disord 26:2154-2159.
52. Shine JM, Halliday GM, Carlos M, Naismith SL, Lewis SJG (2012): Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm. Mov Disord 27:500-505.
53. Shulman GL, Astafiev SV, Franke D, Pope DLW, Snyder AZ, McAvoy MP, et al. (2009): Interaction of stimulus-driven reorienting and expectation in ventral and dorsal fronto-parietal and basal ganglia-cortical networks. J Neurosci 29:4392-4407.
54. Sporns O (2011): Networks of the Brain, 1st ed. MIT Press, Cambridge MA.
55. Smith SM, Miller KL, Moeller S, Xu J, Auerbach EJ, Woolrich MW, et al. (2012): Temporally-independent functional modes of spontaneous brain activity. Proc Natl Acad Sci USA 109:3131-3136.
56. Spreng RN, Stevens WS, Chamberlain JP, Gillmore AW, Schacter DL (2010): Default network activity, coupled with the frontoparietal control network, supports goal-directed cognition. Neuroimage 53:303-317.
57. Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli J. (2004): Altered cortical visual processing in PD with hallucinations: An fMRI study. Neurology 63:1409-1416.
58. Uchiyama M, Nishio Y, Yokoi K, Hirayama K, Imamura T, Shimomura T, Mori E. (2012): Pareidolias: Complex visual illusions in dementia with Lewy bodies. Brain 135:2458-24693.
59. Van den Heuvel MP, Hulshoff Pol HE (2010): Exploring the brain network: A review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20:519-534.
60. Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ (2007): Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC. Mov Disord 22:2221-2228.
61. Yamamoto R, Iseki E, Murayama N, Minegishi M, Marui W, Togo T, Katsuse O, Kosaka K, Kato M, Iwatsubo T, Arai H (2007): Correlation in Lewy pathology between the claustrum and visual areas in brains of dementia with Lewy bodies. Neurosci Lett 415:219-224.